Form 4/A for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-09 · accession 0001104659-23-022065 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-02-14 | 2023-02-09 | RYTM | Chien Jennifer | EVP, Head of North America | S - Sale | $27.51 | -1,204 | 3,544 | -25% | -$33.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | S | D | 1,204 | $27.51 | 3,544 | D | — | — |